About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

New Therapies to Reduce the Radioresistance of Cancer

by Dr. Trupti Shirole on January 16, 2017 at 11:05 PM
Font : A-A+

 New Therapies to Reduce the Radioresistance of Cancer

Many forms of cancer are treated with radiation therapy. However, some cancer cells have the ability to survive this type of treatment.

Oral squamous cell carcinoma (OSCC) is one of these forms of cancer, and is the reason why researchers from Kumamoto University in Japan began searching for methods to combat resistance to radiotherapy.

Advertisement


Rather than going after the cancer cells directly, they attempted to find a way to control the biological mechanisms that aid in radioresistance. This meant looking at interleukin-6 (IL-6), a cytokine known for signaling the inflammatory response, and nuclear factor erythroid 2-related factor 2 (Nrf2), which is a protein that protects against oxidative stress.

Their approach consisted of multiple in vitro experiments on two different cancer cell samples. One sample was derived from tissue specimens taken from consenting patients with advanced OSCC who had undergone chemoradiotherapy (30 Gy total dosage). The other consisted of human OSCC cell lines which were obtained from the Japanese Collection of Research Bioresources Cell Bank (Osaka, Japan). These cells were irradiated with doses of either six or 10 Gy.
Advertisement

The results of the experiments provided evidence that IL-6 provides protection from radiation therapy to cancer cells through interaction with the Nrf2-antioxidant pathway.

"This interaction and the resulting protection from oxidative damage that we have discovered here is very interesting," said Professor Hideki Nakayama, one of the research group leaders. "As far as we know, we are the first to discover that IL-6 has such an effect on the Nrf2-antioxidant pathway. We hope new therapies that target IL-6 will give us an advantage over many types of radiation-resistant cancers."

The majority of the experiments performed were in vitro, which is a limitation of this study. However, research from the same group has already shown in a mouse model that the immunosuppressive drug tocilizumab, a drug currently used for rheumatoid arthritis, is effective against IL-6R as treatment for OSCC. Future research will attempt to expand on the researcher's idea of reducing the radiation resistance of cancer.

This research can be found in the British Journal of Cancer.

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Test  Your Knowledge on Heart
Test Your Knowlege on Genes
Obesity in Teens Make Inroads into Early Atrial Fibrillation
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Cancer and Homeopathy Cancer Facts Cancer Tattoos A Body Art Common Lifestyle Habits that Cause Diseases Health Benefits of Dandelion Plant 

Most Popular on Medindia

Noscaphene (Noscapine) Turmeric Powder - Health Benefits, Uses & Side Effects A-Z Drug Brands in India Pregnancy Confirmation Calculator Diaphragmatic Hernia Vent Forte (Theophylline) Drug Interaction Checker Blood - Sugar Chart Indian Medical Journals Drug - Food Interactions
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

New Therapies to Reduce the Radioresistance of Cancer Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests